Multiple Sclerosis
Conference Coverage
Next up in MS trials: More insight into progressive disease
Results from several treatment trials in progressive MS are expected over the next 2 years.
Conference Coverage
AI tool reveals MS drug interactions, offers safer options
Deep learning–based methods are “useful” in screening for potential interactions both between drugs and with foods.
Conference Coverage
Ocrelizumab benefit confirmed in older patients with MS
Lower rates of relapse were seen in older patients taking ocrelizumab, but the risk for relapse in this age group is low.
Conference Coverage
Obesity linked to multiple ills in MS study
Subjects with excess weight progressed more rapidly and had more cognitive disability.
Conference Coverage
DMT discontinuation trial halted; MS returned in 17.8%
It’s still not clear when – or if – certain patients should take a break from MS therapy.
Feature
Are cellular therapies the future of autoimmune disease?
Promising results from small case studies and early clinical trials hint at the potential of CAR T-cell therapy to treat – and possibly cure –...
Literature Review
New evidence early treatment improves preclinical MS outcomes
“For the first time, we may have an opportunity to better identify those at risk for a primary progressive clinical course at this preclinical...
Conference Coverage
MS drugs during pregnancy show no safety signals
Data on outcomes from cladribine, ocrelizumab, ofatumumab, and ozanimod during pregnancy showed no miscarriages or malformations above the general...
FDA/CDC
FDA okays first biosimilar for multiple sclerosis
“Biosimilar medications offer additional effective treatment options that have the potential to increase access for people living with relapsing...
Literature Review
Early MS treatment tied to a major reduction in severe disability
“With a very early treatment, within 6 months from the first symptoms and even before the MS diagnosis, we are now able to decrease long-term...
Conference Coverage
Retinal thickness a new predictor of MS disability?
The imaging technique cannot be used for all patients and is currently not widely available.